Kerala Ayurveda Ltd

Kerala Ayurveda Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kerala Ayurveda Ltd

₹ 387 1.96%
13 Dec - close price
keralaayurveda.biz BSE: 530163
About

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]

Key Points

Business Overview:[1]
Company manufactures Ayurveda products and deals in Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs, and maintaining a herbarium of medicinal plants

Website BSE
  • Market Cap ₹ 465 Cr.
  • Current Price ₹ 387
  • High / Low ₹ 417 / 235
  • Stock P/E 150
  • Book Value ₹ 30.0
  • Dividend Yield 0.00 %
  • ROCE 6.48 %
  • ROE -4.61 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 12.9 times its book value
  • Company has a low return on equity of -5.64% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
18.99 19.89 20.80 19.09 23.95 23.33 23.84 23.78 25.03 26.32 27.39 27.47 30.41
18.34 15.26 18.70 18.43 21.74 24.93 23.15 22.25 24.49 25.31 24.32 26.67 24.88
Operating Profit 0.65 4.63 2.10 0.66 2.21 -1.60 0.69 1.53 0.54 1.01 3.07 0.80 5.53
OPM % 3.42% 23.28% 10.10% 3.46% 9.23% -6.86% 2.89% 6.43% 2.16% 3.84% 11.21% 2.91% 18.18%
0.85 0.09 0.09 0.10 0.27 2.93 0.11 0.16 0.77 0.23 -0.23 0.22 0.64
Interest 1.68 1.70 1.51 1.19 1.05 1.33 1.25 1.51 0.65 0.61 1.69 0.46 0.72
Depreciation 0.29 0.30 0.31 0.32 0.26 0.29 0.23 0.33 0.32 0.34 0.35 0.36 1.98
Profit before tax -0.47 2.72 0.37 -0.75 1.17 -0.29 -0.68 -0.15 0.34 0.29 0.80 0.20 3.47
Tax % 34.04% 0.74% 97.30% 8.00% 12.82% 279.31% -170.59% 106.67% 100.00% 368.97% 86.25% -125.00% -4.90%
-0.62 2.70 -0.00 -0.82 1.01 -1.10 0.47 -0.30 -0.00 -0.79 0.10 0.46 3.65
EPS in Rs -0.59 2.56 -0.03 -0.85 0.98 -1.16 0.17 -0.34 -0.12 -0.90 -0.13 0.27 2.83
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
31 35 39 46 50 59 59 77 62 80 93 108 112
28 31 33 38 43 51 54 69 61 71 91 101 101
Operating Profit 3 4 6 8 7 8 5 7 1 10 3 7 10
OPM % 9% 11% 15% 16% 14% 14% 9% 10% 1% 12% 3% 6% 9%
0 0 0 0 0 0 1 0 0 1 3 1 1
Interest 1 1 2 2 1 2 3 2 6 7 5 5 3
Depreciation 2 1 1 2 2 2 1 1 1 1 1 1 3
Profit before tax 0 2 3 4 4 4 3 5 -7 3 -1 1 5
Tax % 412% 48% 21% 33% 22% 31% 19% 11% -28% 15% -23% 168%
-0 1 3 3 3 3 3 4 -5 2 -0 -1 3
EPS in Rs -0.58 0.70 2.24 2.56 2.90 2.66 2.31 3.69 -4.59 2.24 -0.85 -1.27 2.07
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: 12%
5 Years: 13%
3 Years: 20%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 22%
TTM: 190%
Stock Price CAGR
10 Years: 26%
5 Years: 58%
3 Years: 80%
1 Year: 52%
Return on Equity
10 Years: %
5 Years: -6%
3 Years: -6%
Last Year: -5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 11 11 11 11 11 11 11 11 11 11 11 12 12
Reserves -22 -21 -19 -17 -4 -3 -7 -3 -7 -4 -5 20 24
64 66 70 69 56 75 62 64 77 70 72 68 64
10 11 11 11 17 20 27 31 34 34 37 41 39
Total Liabilities 63 66 73 73 81 103 92 103 114 110 115 141 139
34 35 33 34 34 32 33 33 33 44 46 46 51
CWIP -0 -0 -0 -0 6 11 12 14 14 4 7 7 9
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
29 32 40 39 41 59 47 56 68 62 61 88 79
Total Assets 63 66 73 73 81 103 92 103 114 110 115 141 139

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-8 -0 0 6 4 -10 12 5 7 -0 10 2
-4 -1 -0 -3 -3 -3 -3 -4 -1 -2 -7 -1
11 1 2 -2 0 17 -12 1 6 -13 -1 18
Net Cash Flow -0 -1 2 -0 1 4 -2 2 12 -16 2 18

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 47 36 35 33 35 34 43 51 61 61 51 53
Inventory Days 223 413 287 227 319 338 311 313 268 254 227 258
Days Payable 160 245 150 100 112 125 117 162 149 168 137 129
Cash Conversion Cycle 110 204 172 160 242 247 236 202 179 147 141 182
Working Capital Days -0 5 19 26 49 138 50 37 8 30 5 17
ROCE % 2% 5% 8% 9% 9% 9% 6% 9% -0% 11% 2% 6%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
61.52% 61.52% 61.52% 61.52% 61.52% 61.52% 61.52% 61.52% 63.44% 58.58% 58.58% 58.58%
0.29% 0.29% 0.29% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.03% 0.03% 0.03%
38.20% 38.20% 38.20% 38.42% 38.43% 38.43% 38.44% 38.43% 36.51% 41.37% 41.39% 41.38%
No. of Shareholders 8,2108,2858,1328,0628,0797,9667,7807,8558,4288,5818,6559,052

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Nov 2018
    Transcript
    Notes
    PPT